WCLC 2022 Congress Round-Up Archives

IMpower010: First interim OS analysis of adjuvant atezolizumab in NSCLC

Presented By

Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain

Trial

Phase 3, IMpower010

Conference

WCLC 2022

23 August, 2022 11:02

Presented By

Dr Nasser Altorki, Weill Cornell Medicine, NY, USA

Trial

Phase 3, CALGB 140503

Conference

WCLC 2022

23 August, 2022 10:57